← Eichor
Study identifier: NCT06292585 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)

Condition: EpiDural Hematoma · Traumatic Brain Injury  ·  Sponsor: Changhai Hospital

PhaseNA
Planned participants194
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A prospective, multicenter, randomized controlled, open-label, blinded endpoint evaluation study.

This description comes directly from the study's public registry record.

Talk to the study team

Pengfei Yang, M.D.  ·  86-21-31161784  ·  15921196312@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Changhai hospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06292585